pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›approval
approval
save

INBRIJA (LEVODOPA) — FDA approval

March 31, 2026levodopaupdated 5mo ago
community read0 votes

Sponsor: MERZ. Form: POWDER. Route: INHALATION

view source ↗
Data sources
fda approvals
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 4

  • approvalINBRIJA (LEVODOPA) — FDA approvalAug 31, 2020 · 2225d ago
  • approvalINBRIJA (LEVODOPA) — FDA approvalAug 31, 2020 · 2225d ago
  • approvalINBRIJA (LEVODOPA) — FDA approvalAug 29, 2019 · 2593d ago
  • approvalINBRIJA (LEVODOPA) — FDA approvalDec 21, 2018 · 2844d ago

same company · ±60 days · 2

  • approvalXeomin (incobotulinumtoxinA) — FDA approvalMar 20, 2026
  • approvalXeomin (incobotulinumtoxinA) — FDA approvalFeb 26, 2026

🐶 often sniffed alongside

top 8
  • drugINBRIJA31 co-mentions · 8 sources
  • tagApproval22 co-mentions · 6 sources
  • druglevodopa CR21 co-mentions · 8 sources
  • drugSINEMET CR12 co-mentions · 3 sources
  • drugentacapone10 co-mentions · 2 sources
  • tagRecall3 co-mentions · 1 sources
  • companyRising Pharma Holdings Inc3 co-mentions · 1 sources
  • drug(carbidopa + levodopa)1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?